Literature DB >> 3674851

Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.

W Brumfitt1, J M Hamilton-Miller, G W Smith.   

Abstract

Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily). The poor performance of cefuroxime axetil is explained by variable bioavailability.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3674851      PMCID： PMC174961          DOI： 10.1128/AAC.31.9.1442

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Br J Clin Pract       Date:  1985-09

2.  Cefuroxime - a new cephalosporin antibiotic.

Authors:  C H O'Callaghan; R B Sykes; D M Ryan; R D Foord; P W Muggleton
Journal:  J Antibiot (Tokyo)       Date:  1976-01       Impact factor: 2.649

3.  The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.

Authors:  R Wise; S A Bennett; J Dent
Journal:  J Antimicrob Chemother       Date:  1984-06       Impact factor: 5.790

4.  A concise biotyping system for differentiating strains of Escherichia coli.

Authors:  R Gargan; W Brumfitt; J M Hamilton-Miller
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

5.  Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.

Authors:  D H Adams; M J Wood; I D Farrell; C Fox; A P Ball
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

6.  A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.

Authors:  T J Cooper; E Ladusans; P E Williams; V Polychronopoulos; H Gaya; R M Rudd
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

7.  Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.

Authors:  S M Harding; P E Williams; J Ayrton
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.

Authors:  P E Williams; S M Harding
Journal:  J Antimicrob Chemother       Date:  1984-02       Impact factor: 5.790

9.  Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections.

Authors:  W Brumfitt; J M Hamilton-Miller; H Ludlam; V Damjanovic; R Gargan
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

10.  Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection.

Authors:  W Brumfitt; G W Smith; J M Hamilton-Miller; R Bax
Journal:  J Antimicrob Chemother       Date:  1985-12       Impact factor: 5.790
View more
  2 in total

1.  Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice.

Authors:  J Cooper; A Raeburn; W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

Review 2.  Optimal characteristics of agents to treat uncomplicated urinary tract infections.

Authors:  H C Neu
Journal:  Infection       Date:  1992       Impact factor: 3.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.